F5 Inc. CTO Awarded 8,013 Restricted Stock Units
F5, INC.
Subscribe to track FFIV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
F5 Inc. CTO Awarded 8,013 Restricted Stock Units
Company: F5, INC. (FFIV) Form: 4 | Filed: 2025-11-05 Significance: Low
Insider: ANAND KUNAL Title: Chief Technology Officer | Relationship: Officer
Transaction: • Type: Grant • Shares: 8,013 RSUs • Price: $0.00 • Value: $0 • Owned After: 8,013 RSUs
Key Insight: This is a routine service-based Restricted Stock Unit (RSU) grant for the CTO as part of an executive compensation package. The grant represents a negligible percentage of shares outstanding.
Market Context: The grant has a 3-year vesting schedule, aligning the executive's interests with long-term shareholder value. An equal number of performance-based RSUs were also granted, contingent on future company performance.
Comprehensive Analysis
SEC Filing Analysis: F5, INC. (FFIV)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Technology Officer, Kunal Anand, received a routine grant of 8,013 Restricted Stock Units (RSUs) as part of his compensation package.
- Market Impact: Neutral. This is a standard equity award with minimal immediate market impact or dilution.
Company Information
| Field | Value |
|---|---|
| Company | F5, INC. |
| Ticker Symbol | FFIV |
| CIK | 0001048695 |
| Industry | Computer Communications Equipment |
Insider Information
| Field | Value |
|---|---|
| Name | ANAND KUNAL |
| CIK | 0002016857 |
| Title/Position | Chief Technology Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-03 |
| Transaction Code | A (Grant) |
| Security Type | Restricted Stock Unit |
| Shares Involved | 8,013 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 8,013 (Derivative Securities) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 8,013 |
| % of Shares Outstanding | 0.014% |
| Post-Transaction Ownership | 8,013 RSUs (potential for <0.1% of common stock upon vesting) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a $14.60 billion market capitalization, this grant is immaterial in value.
- Dilution Impact: The potential dilution from this grant is minimal, representing just 0.014% of the total shares outstanding. The impact is further spread out over a three-year vesting period, which mitigates any immediate effect on existing shareholders.
- Transaction Significance: The transaction is a standard component of executive compensation designed to retain key talent and align their interests with the company's long-term performance. Its size and nature do not signal any new information to the market.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to executives are a common and expected practice. This transaction does not provide any new insight into the company's current performance or future prospects.
Volume & Sentiment
- Expected Volume Impact: None. This is a non-market transaction and will not affect trading volume.
- Sentiment Indicator: Neutral. The filing is informational and aligns with standard corporate governance practices.
Additional Context
Transaction Notes
- Vesting Schedule: The RSUs vest in twelve equal quarterly increments starting February 1, 2026, indicating a standard three-year vesting period.
- Special Circumstances: A footnote reveals the grant of additional performance-based RSUs (up to 8,013), which will only be issued if specific performance targets are met. This adds a performance incentive to the compensation package.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
